Jill Murphy is an associate editor for Pharmacy Times®. She graduated from Monmouth University in 2018 in communication and was previously a copywriter and communications specialist at a marketing agency prior to her start at the publication.
Study: People Living with HIV/AIDS at Significantly Higher Risk of Suicide
July 8th 2021Despite significant medical advancements related to HIV treatment and quality of life, the risk of suicide in patients is high and health care providers should prioritize mental health screenings in this population.
Read More
Study: Eating Patterns Could Affect Risk of Heart Disease Mortality
June 30th 2021The research concluded that eating starchy snacks after meals and eating a Western-style lunch containing refined grains, cheese, and cured meat elevates the risk of dying from heart disease and other illnesses.
Read More
Study Reinforces Community Pharmacists Play a 'Key Clinical Role' in COVID-19 Vaccination Process
June 23rd 2021The research team discovered that community pharmacists, as a skilled clinical workforce, could positively contribute to the future of COVID-19 vaccination programs by continuing to be active in COVID-19 vaccination campaigns.
Read More
Study Finds No Benefit to Adding Checkpoint Inhibitors to Anti-HER2 Breast Cancer Therapy
June 21st 2021The trial, in phase 3, is the first to report data comparing a neoadjuvant anti-HER2 based regimen with or without the anti-PD-L1 antibody, atezolimumab, in patients with high-risk, HER2-positive early breast cancer.
Read More
FDA Approves Avapritinib for Advanced Systemic Mastocytosis
June 16th 2021Avapritinib is approved for adult patients with advanced systemic mastocytosis, including individuals with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.
Read More